Catalog Number 810081L |
Device Problem
Migration or Expulsion of Device (1395)
|
Patient Problems
Erosion (1750); Pain (1994); No Code Available (3191)
|
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.(b)(4).Total number of events ¿ (b)(4).Gynecare tvt ¿ (b)(4).Gynecare tvt abbrevo ¿ (b)(4).Gynecare tvt exact continence system ¿ (b)(4).Gynecare tvt obturator system ¿ (b)(4).Gynecare tvt retropubic system ¿ (b)(4).Gynecare tvt-aa abdominal ¿ (b)(4).
|
|
Event Description
|
It was reported by an attorney that the patient underwent a gynecological surgical procedure on (b)(6) 2009 and the mesh was implanted due to uterine prolapse, cystocele, rectocele and stress urinary incontinence.Following the procedure, the patient experienced pain and erosion and underwent revision surgeries.No further information is available.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2016.
|
|
Manufacturer Narrative
|
Date sent to the fda: 04/20/2017.Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(4) 2016.
|
|
Manufacturer Narrative
|
Date sent to the fda: 08/29/2017.Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.Supplemental 05 - attachment: [(b)(4) otn supplemental 05.Xlsx].
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2016 through (b)(4) 2016.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4)
reporting period (b)(6) 2016 through (b)(6) 2016
supplemental 06 - attachment: [(b)(6) 2016 otn supplemental 06.Xlsx].
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
|
|
Manufacturer Narrative
|
Date sent to fda: (b)(4) 2018.Ethicon mdr summary reporting exemption e2013037
reporting period (b)(4) 2016 through (b)(4) 2016.
|
|
Manufacturer Narrative
|
Date sent to fda: 12/27/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
|
|
Manufacturer Narrative
|
Date sent to fda: 6/25/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
|
|
Manufacturer Narrative
|
Date sent to fda: 02/17/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
|
|
Manufacturer Narrative
|
Date sent to fda: 04/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
|
|
Manufacturer Narrative
|
Date sent to fda: 02/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
|
|
Manufacturer Narrative
|
Date sent to fda: 10/282019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
|
|
Manufacturer Narrative
|
Date sent to fda: 04/19/2021.
|
|
Manufacturer Narrative
|
Date sent to fda: 06/18/2021.
|
|
Search Alerts/Recalls
|